Experimental hepatitis b treatment trial halted before starting
NCT ID NCT02349126
Summary
This study aimed to test whether adding an experimental drug called ARC-520 to standard Hepatitis B medications could better control the virus. It was designed for adults already taking daily antiviral pills. The trial was withdrawn by the sponsor before any patients were enrolled.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC HEPATITIS B are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Research Site 1
Melbourne, Victoria, 3004, Australia
Conditions
Explore the condition pages connected to this study.